Issue 42, 2009

MRI contrast agent delivery using spore capsules: controlled release in blood plasma

Abstract

The exine coatings of spores can be used to encapsulate drug molecules. We have demonstrated that these microcapsules can be filled with a commercial gadolinium(III) MRI contrast agent (in this proof of concept study Gd–DTPA–BMA was used) which is slowly released in plasma due to enzymatic digestion of the capsule.

Graphical abstract: MRI contrast agent delivery using spore capsules: controlled release in blood plasma

Supplementary files

Article information

Article type
Communication
Submitted
13 May 2009
Accepted
08 Sep 2009
First published
01 Oct 2009

Chem. Commun., 2009, 6442-6444

MRI contrast agent delivery using spore capsules: controlled release in blood plasma

M. Lorch, M. J. Thomasson, A. Diego-Taboada, S. Barrier, S. L. Atkin, G. Mackenzie and S. J. Archibald, Chem. Commun., 2009, 6442 DOI: 10.1039/B909551A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements